Washington, D.C. 20549 FORM S-1 As filed with the Securities and Exchange Commission on February 17, 2026 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aspire Biopharma Holdings, Inc. (Exact name of registrant as specified in its charter) (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 33-3467744 (I.R.S. Employer Identification No.) 23150 Fashion Dr ...

As filed with the Securities and Exchange Commission on February 17, 2026 Washington, D.C. 20549 Registration No. 333- FORM S-1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aspire Biopharma Holdings, Inc. (Exact name of registrant as specified in its charter) (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 33-3467744 (I.R.S. Employer Identification No.) 23150 Fashion Dr ...

FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aspire Biopharma Holdings, Inc. As filed with the Securities and Exchange Commission on December 3, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Exact name of registrant as specified in its charter) (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 33-3467744 (I.R.S. Employer Identification No.) 23150 Fashion Dri ...

As filed with the Securities and Exchange Commission on December 3, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aspire Biopharma Holdings, Inc. (Exact name of registrant as specified in its charter) (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 33-3467744 (I.R.S. Employer Identification No.) 23150 Fashion Dri ...

Group 1 - Fairfax Financial Holdings Limited has declared quarterly dividends per share on its preferred shares, with specific amounts and payment dates outlined for Series G, H, I, J, and K [1] - The dividend amounts for Series G, H, I, J, and K are C$0.185125, C$0.32792, C$0.207938, C$0.34620, and C$0.315313 respectively, with payment dates on September 29 and 30, 2025 [1] - Applicable Canadian withholding tax will be applied to dividends payable to non-residents of Canada [1] Group 2 - Fairfax has determined the quarterly dividend rate for its floating rate preferred shares for the period from September 30, 2025, to December 30, 2025, with Series J having a rate of 1.38907% and an annualized rate of 5.51099% [2] - The dividend per share for Series J is set at C$0.34727 for the specified period [2] - Fairfax operates primarily in property and casualty insurance and reinsurance, along with associated investment management through its subsidiaries [2] Group 3 - Fairfax intends to redeem all outstanding Cumulative 5-Year Rate Reset Preferred Shares, Series G, and all outstanding Cumulative Floating Rate Preferred Shares, Series H, on September 30, 2025 [3]

Dividend Announcements - Fairfax Financial Holdings Limited has declared quarterly dividends per share on its preferred shares, with specific amounts and payment dates outlined for Series G, H, I, J, and K [1] - The dividends for Series G, H, I, J, and K are C$0.185125, C$0.33645, C$0.207938, C$0.35452, and C$0.315313 respectively, with payment dates on June 30, 2025, and June 27, 2025 [1] Floating Rate Preferred Shares - The company has determined the quarterly dividend rates for the period from June 30, 2025, to September 29, 2025, for its floating rate preferred shares [2] - Series H has a rate of 1.31169% (annualized 5.20399%) with a dividend of C$0.32792, while Series J has a rate of 1.38479% (annualized 5.49399%) with a dividend of C$0.34620 [2] Company Overview - Fairfax is primarily engaged in property and casualty insurance and reinsurance, along with associated investment management through its subsidiaries [2]